Birth Asphyxia
0
Pipeline Programs
4
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
4 companies ranked by most advanced pipeline stage
Sharp TherapeuticsPA - Pittsburgh
2 programsUmbilical Cord MilkingN/A1 trial
Umbilical Cord MilkingN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Sharp TherapeuticsUmbilical Cord Milking
Sharp TherapeuticsUmbilical Cord Milking
Clinical Trials (2)
Total enrollment: 1,957 patients across 2 trials
Echocardiography Sub-Study of the Umbilical Cord Milking in Non-Vigorous Infants Trial (MINVI)
Start: Jan 2019Est. completion: Nov 2022227 patients
N/ACompleted
Umbilical Cord Milking in Non-Vigorous Infants
Start: Jan 2019Est. completion: Sep 20231,730 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
4 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.